- Co-founder, chair of the Board, CEO and holder of an executive leadership role overseeing all research and non-research functions, Rallybio LLC.
- Senior advisor to New Leaf Venture Partners, LLC.
- Member of the board and member of the Science and Technology Committee and the Finance committee of Charles River Laboratories International, Inc.
- President of Global Research and Development at AstraZeneca plc., 2010-2013.
- President and senior vice president within Research and Development, and other roles, Pfizer, Inc., 1995-2010.
- Visiting professor at the Department of Pharmacy at King’s College, London, 1998-2006 and at the Department of Biomedical Sciences at the University of Lincoln, 1998-2014.
- Considered independent under the Danish Recommendations on Corporate Governance.
- Member of the Board of Directors since March 2018. Most recently elected in 2022 for a term of one year.
- Chair of the Research & Development Committee since March 2018.
- Member of the Remuneration Committee since March 2021.
- Global corporate leadership
- Healthcare and pharma industry
- Medicine & science
- Technology
- Business development, M&A and external innovation sourcing
- Human capital management
- 1984: Doctorate/PhD, University of Edinburgh, UK.
- 1979: BSc (First Class Honours) in Microbiology, Heriot-Watt University, Edinburgh, UK.
US and British national, born 1956. Male.
